e-Edition
Obituaries
In Loving Memory
Magazines
Subscribe
Login to Comment
Register
jobs
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Life
Commentary
Contact
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
HEALTHCARE
(NY:
XLV
)
150.18
+1.07 (+0.72%)
Official Closing Price
Updated: 8:00 PM EST, Nov 8, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about HEALTHCARE
< Previous
1
2
3
4
5
6
7
8
9
...
22
23
Next >
XLV Making Strong Reaction Higher From Extreme Area
January 03, 2024
In this article, we will look at the past performance of the 4-hour Elliott Wave Charts of XLV
Via
Talk Markets
Did Santa Claus Claus Leave Town A Day Early?
January 02, 2024
With the exception of the Dow, stocks are down hard to begin the new calendar year.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
3 Biotech Stocks Set for Breakthroughs in 2024
January 02, 2024
With groundbreaking advancements in new medicine and science, 2024 holds a promising future for these biotech stocks.
Via
InvestorPlace
Tech Drags On Wall Street As 2024 Kicks Off; Dollar and Treasury Yields Surge: What's Driving Markets Tuesday?
January 02, 2024
Wall Street kicked off 2024 on a weaker note, with the S&P 500 dipping by 0.5%, and the Nasdaq 100 experiencing a 1.4% decline in midday trading in New York.
Via
Benzinga
2023 Russell 1,000 Average Stock Performance By Sector
January 02, 2024
2023 turned out to be a fantastic year for stocks after a horrible 2022.
Via
Talk Markets
The Short-Term Uptrend May Be On Its Last Legs
December 31, 2023
Believe it or not, the short-term uptrend looks set to continue, but it does appear to be on its last legs. It's time to prepare for a pullback in prices by having cash to deploy back into stocks when...
Via
Talk Markets
Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024
December 29, 2023
According to the Global Data report, the pharma sector in Q3 2023 witnessed deals worth $28 billion, down 28% from the $54 billion recorded in Q2 2023.
Via
Benzinga
S&P 500 Stuck In 4600-4800 Limbo For 2024? Wells Fargo Pinpoints 3 'Favored Sectors' For Next Year
December 26, 2023
Wells Fargo Investment Institute has a 4600-4800 year-end 2024 target for the S&P 500 Index and 2000-2200 for the MSCI EAFE Index. Favored sectors are Health Care, Industrials, and Materials.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Wall Street Sees Post-Holiday Gains, Oil Rallies, Intel Leads: What's Driving Markets Tuesday?
December 26, 2023
The U.S. stock market saw modest gains in a session characterized by low trading volumes following the Christmas holiday. The S&P 500 Index gained 0.3% during midday trading in New York, eyeing its...
Via
Benzinga
Align Technology: Protected by more factors than any other stock
December 26, 2023
Jobs are flowing to the healthcare space, and investment dollars are finding a home in stocks like Align Technology, even the CEO thought it to be the best
Via
MarketBeat
Pfizer's chaotic year wraps up with plunging stock, grim guidance
December 21, 2023
Pfizer's tumultuous 2023 included a 41.84% stock plunge as revenue from Covid drugs fell. Disappointing 2024 guidance resulted in analysts slashing targets.
Via
MarketBeat
Exposures
COVID-19
3 Stocks With the Potential to Be 2024’s Company of the Year
December 18, 2023
Finding the top stocks for 2024 is like looking for a needle in a haystack. Nonetheless, some of these names could be company of the year.
Via
InvestorPlace
Santa Rally Boosts Real Estate Stocks: 5 ETF Picks To Ride The Fed Rate Cut Wave
December 14, 2023
Federal Reserve Chair Jerome Powell signals possible rate cuts in 2024, sending real estate stocks soaring to outperform all other sectors in the S&P 500.
Via
Benzinga
Topics
ETFs
Economy
Stocks
Exposures
Interest Rates
US Equities
Cigna Drops Humana Merger, Opts For $10 Billion Buyback Strategy
December 10, 2023
In a recent development in the health insurance sector, Cigna Corporation (NYSE: CI) has withdrawn from its proposed merger with Humana Inc. (NYSE:
Via
Benzinga
UAW's Return To Work Pushes US Jobs Growth Higher, But Dark Clouds Hover Over Retail Sector
December 08, 2023
Nearly a quarter of the 199,000 jobs added in November were due to returning UAW strikers. Here's a deeper dive into the numbers.
Via
Benzinga
Wall Street Revels In Gains As AI, Tech Titans Surge; Dollar Plunges Against Yen: What's Driving Markets Thursday?
December 07, 2023
Wall Street was enjoying a bullish Thursday afternoon, propelled by AI stocks and tech giants, as investors grew increasingly optimistic about the disruptive technology.
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
SPDR ETF Report For Monday, Dec. 4
December 04, 2023
A review of the day's trading in various SPDR-ETF markets for the trading day.
Via
Talk Markets
Topics
ETFs
Fed Rate Cut Speculations Rattle Stocks, Commodities Slide, Bitcoin Shines: What's Driving Markets Monday?
December 04, 2023
Stocks opened the first week of December with significant losses, driven by some emerging concerns of exaggerated rate cut speculations within the trading community.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Mega merger in the works? Humana, Cigna explore big deal
December 02, 2023
Humana and Cigna are exploring a merger, aiming to conclude the deal before year-end, creating a healthcare giant with a potential market value of $137 billion.
Via
MarketBeat
Stocks, Gold, Bonds Rally Further, Dollars Tumbles As Traders Anticipate Fed Cuts: What's Driving Markets Friday?
December 01, 2023
Kicking off the new month, Wall Street continued its strong November momentum, with major U.S. stocks rallying on Friday.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
S&P 500, Nasdaq Slip As Tech Underperforms, Oil Reacts to OPEC+: What's Driving Markets Thursday?
November 30, 2023
Thursday’s trading session on Wall Street presents a mixed picture, characterized by notable fluctuations in major indices. While tech-heavy benchmarks like the S&P 500 and the Nasdaq 100 are...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Chilling 2024 S&P 500 Outlook: Why JPMorgan Analysts Project Nightmare Scenario For Stocks
November 30, 2023
JP Morgan is bearish on the US stock market in 2024, predicting an 8% drop. They point to rich valuations, aging cycle, restrictive monetary policy, geopolitical risks, and rising debt costs as factors...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Thoughts For Thursday: No Pre-Santa Rally Correction In Sight But No Rally Either
November 30, 2023
Talk of a pre-Santa Claus rally, market correction have yet to materialize but the same can be said of the rally itself. Yesterday, the stock market remained in same static mode.
Via
Talk Markets
ETFs In Focus As Buffett's Cash Surge Indicates A Likely Recession
November 29, 2023
According to Steve Hanke, Berkshire Hathaway’s increasing cash reserves indicate the possibility that ‘The Oracle of Oklahoma’ is bracing for a projected economic downturn or even a recession, waiting...
Via
Talk Markets
Topics
ETFs
Economy
Exposures
Economy
Stocks Drift Higher On Stronger GDP Data, Oil Rebounds As OPEC+ Mulls Cuts: What's Driving Markets Wednesday?
November 29, 2023
Stocks are experiencing their 16th green session out of the 20 so far in November, with the S&P 500 index reaching its highest level since early August, and the Nasdaq 100 just 4.4% below its all-time...
Via
Benzinga
These are the top sectors for blue chip growth in 2024
November 29, 2023
The sector results will be mixed in 2024 but the Health Care, Communications and Technology sectors (and some of their stocks) will post robust gains.
Via
MarketBeat
Topics
Economy
Intellectual Property
Exposures
COVID-19
Intellectual Property
Interest Rates
J&J, Gilead, BMS: A look at undervalued dividend payers
November 29, 2023
J&J, Gilead and Bristol Myers are among healthcare stocks with defensive qualities amid market volatility and a potential economic slowdown
Via
MarketBeat
US Stocks Rebound As Treasury Yields, Dollar Fall On Dovish Fed Remarks, Gold Hits $2,040: What's Driving Markets Tuesday?
November 28, 2023
U.S. stocks experienced a welcome resurgence on Tuesday, buoyed by the latest comments from Federal Reserve officials.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
US Stocks Slip, Tech Rises On Solid Holiday Sales, Treasury Yields Soften: What's Driving Markets Monday?
November 27, 2023
U.S. stocks are kicking off the week with a slight dip, as all major indices trade in the red in New York, except for the tech stocks of the Nasdaq 100, which are showing positive momentum following...
Via
Benzinga
Biotech And Healthcare Portfolio Playbook For December 2023/24
November 27, 2023
We are having a great but choppy market recovery over the past four weeks and it looks like it should continue through to the next earnings cycle in January.
Via
Talk Markets
< Previous
1
2
3
4
5
6
7
8
9
...
22
23
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
wpDiscuz
Insert